In this update, there were lots of press around cross-state care and reciprocity of state licenses, with highlights from board members Amwell and Johns Hopkins Medicine. Notable administration actions included the release of the OMB Spring 2022 Unified Agenda of Regulatory and Deregulatory Actions, and the White House ONDCP report.
